4.6 Article

Does the Presence of Accessory Renal Arteries Affect the Efficacy of Renal Denervation?

期刊

JACC-CARDIOVASCULAR INTERVENTIONS
卷 6, 期 10, 页码 1085-1091

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jcin.2013.06.007

关键词

accessory; arterial hypertension; radio-frequency ablation; renal artery; renal denervation

资金

  1. Abbott
  2. Access Closure
  3. AGA Medical
  4. Angiomed
  5. Aptus
  6. Arstasis
  7. Atritech
  8. Atrium
  9. Avinger
  10. Bard
  11. Boston Scientific
  12. Bridgepoint
  13. Cardiac Dimensions
  14. CardioKinetix
  15. CardioMEMS
  16. Coherex
  17. Contego
  18. Cardiovascular Systems, Inc.
  19. CVRx, Inc.
  20. EndoCross
  21. EndoTex
  22. Epitek
  23. ev3
  24. FlowCardia
  25. Gore
  26. Guidant
  27. Guided Delivery Systems, Inc.
  28. InSeal Medical
  29. Lumen Biomedical
  30. Heart Leaflet Technologies, Inc.
  31. Kensey Nash
  32. Kyoto Medical
  33. Lifetech
  34. Lutonix
  35. Maya Medical
  36. Medinol
  37. Medtronic
  38. Nitinol Medical Therapies, Inc.
  39. Nitinol Devices and Components, Inc.
  40. OAS Medical
  41. Occlutech
  42. Osprey
  43. Ovalis
  44. Pathway
  45. PendraCare
  46. Percardia
  47. pfm Medical
  48. Recor
  49. ResMed
  50. Rox Medical
  51. Sadra
  52. Sorin
  53. Spectranetics
  54. SquareOne
  55. Trireme
  56. Trivascular
  57. Velocimed
  58. Venus Medical
  59. Veryan
  60. Vessix

向作者/读者索取更多资源

Objectives This study sought to assess the efficacy of catheter-based renal sympathetic denervation in patients with accessory renal arteries and to compare the blood pressure (BP)-lowering effect with that observed in patients with bilateral single renal arteries after renal denervation. Background Catheter-based renal sympathetic denervation causes significant BP reductions in patients with resistant hypertension. Methods Seventy-four patients were included in this study. Patients were assigned to 2 main groups: a bilateral single renal arteries group I (n = 54) and an accessory renal arteries group II (n = 20). Group II consisted of 9 patients whose accessory renal arteries were all denervated (group IIa), and 11 patients whose accessory renal arteries were not, or only incompletely, denervated (group IIb). The primary endpoint was the change in office systolic BP after 6 months. Results The procedure was successful in all patients. Group I: mean BP at baseline was 166.2/89.4 +/- 20.5/14.6 mm Hg and decreased by -16.6 (p < 0.001)/-6.7 (p = 0.016) +/- 16.4/11 mm Hg at 6-month follow-up. Group II: mean BP at baseline was 164.2/89.1 +/- 19.9/15.4 mm Hg and decreased by -6.2 (p = 0.19)/-0.2 (p = 0.5) +/- 19.7/11.3 mm Hg at 6-month follow-up. Patients in group IIa had an office BP reduction of -8.8 (p = 0.2)/1.1 +/- 17.9/10.8 mm Hg and patients in group IIb of -4.1 (p = 0.55)/-1.3 +/- 20.8/11.6 mm Hg. Similarly, significant improvements in 24-h mean systolic BP were seen in group I (-8.3 +/- 17.4 mm Hg, p < 0.01), whereas none were seen in group II (-3.7 +/- 8.3 mm Hg, p = 0.38). Conclusions BP reduction achieved after renal denervation in patients with accessory renal arteries is less pronounced than in patients with bilateral single renal arteries. (C) 2013 by the American College of Cardiology Foundation

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据